Isotope imaging for metastatic thyroid cancer

被引：28

作者：

Haugen, BR

Lin, EC

机构：

[1] Univ Colorado, Hlth Sci Ctr, Div Endocrinol Diabet & Metab, Denver, CO 80206 USA

[2] Univ Colorado, Hlth Sci Ctr, Thyroid Tumor Ctr, Denver, CO 80206 USA

来源：

ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA | 2001年 / 30卷 / 02期

关键词：

D O I：

10.1016/S0889-8529(05)70195-X

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Many agents are available for imaging patients with differentiated thyroid carcinoma and suspected recurrent or persistent disease. These agents include I-131, I-123, (18)FDG, Tc-99m-sestamibi, (201)Thallium, Tc-99m-terofosmin, (111)Indium-octreotide, Tc-99m-pertechnetate, Tc-99m-furifosmin. This article examines the sensitivity and specificity of these imaging agents and proposes an imaging algorithm as an approach to patients with differentiated thyroid carcinoma. Emphasis is focused on two newer imaging modalities,I-123 WBS and (18)FDG-PET.

引用

页码：469 / +

页数：25

共 88 条

[1] Diagnostic value of technetium-99m methoxyisobutyl isonitrile (99mTc-MIBI) scintigraphy in detecting thyroid cancer metastases:: A critical evaluation [J].